Published in Cancer Weekly, January 27th, 2009
"Measurement of tumor blood flow was followed by an F-18-EF5 PET/CT scan. On a separate day, F-18-FDG PET/CT was performed to determine the metabolically active tumor volume. In 6 patients, dynamic F-18-EF5 images of the head and neck area were acquired, followed by static images acquired at 1, 2, and 3 h after injection. In the remaining 9 patients, only...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.